Relapsed and/or refractory multiple myeloma Clinical Trials

Delta Trials records 21 clinical trials for Relapsed and/or refractory multiple myeloma in its publicly accessible dataset. From the full dataset, 3 actively seeking eligible participants and 8 trials have reached completion. This research is conducted across 246 study locations around the world. An additional 10 trials are active but not currently open for enrollment. Since 2020, 3 trials have been stopped, reflecting shifts in research priorities or feasibility. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.